University Hospital Sharjah makes progress treating migraine headaches by Botox injection
WAM SHARJAH, 28th August, 2013 (WAM) -- University Hospital Sharjah (UHS) has made remarkable progress in the treatment of chronic migraine headaches by Botox injection, a new treatment protocol was introduced by Dr. Susan Ibrahim Nouri, Neurology Consultant and Multiple Sclerosis Specialist.
UHS's medical team have been able to effectively deal with numerous advanced migraine headache conditions thanks to the skill of the medical team in determining the type and quantity of Botox doses and the therapy sessions as well as in following up on the treatment's development and impact. This has helped relieve pain and accelerate patient's response. In the case of one patient who had been suffering from chronic, nearly daily, migraines, the team managed to eradicate a patient's pain for a period of 60 days.
The new treatment is a major step forward in combating the effects of migraines, which are one of the most common medical reasons for absence from work.
The treatment has been proven to be effective in providing lasting relief from the effects of migraines, thus contributing to raising individual productivity and supporting family, career, and social stability. Migraine symptoms that can be effectively relieved by the treatment include, blurred vision, sensitivity to sound and light, and nausea among many others.
Speaking on the therapy, Dr Susan Ibrahim Nouri, Neurology Consultant and Multiple Sclerosis Specialist, said: "Treating migraine headaches by Botox involves injecting Botox into 31 sites in the head, neck and shoulder. This treatment is approved by a protocol issued by US Food and Drug Administration, based on the result of studies that showed evidence of improvement through its use." She added: "Effective relief is shown about 7-10 days post injection and the treatment helps stop migraine headache problems for a period up to 3 months, before the Botox fades and a new series of injection is needed to achieve best results. Botox is a safe, complication free treatment that has been proven successful in curing such diseases as muscle stiffness caused by a stroke, spinal cord injuries, migraine facial paralysis, and inconsistency in hand muscle movement." She continued that "We are striving to study advanced conditions and are eager to stay abreast with the latest global developments in treatment. I think we will see more progress in treating the disease in the coming period. UAE medicine will prove its competitiveness and enhance its profile after the positive results and high rate of recovery from this disease and through supporting medical research with more findings." The vast majority of people worldwide will experience a migraine headache at least once during their lifetime. Several international studies showed that the lifetime prevalence of headache range from 93% in men to 99% among women, 15% of which are due to genetic factors. In a 56-week study that covered 95 medical centres in 6 countries (USA, Canada, and European countries) and 1834 individuals, the response increased from 44% to 51% in 24 weeks. These results helped develop a more optimistic outlook about the cure of the migraine headache. The UAE is among the first countries in the region to adopt this medical technology.
The inauguration of the University Hospital Sharjah in 2011 under the directives of His Highness the Ruler of Sharjah has been a quality addition to the healthcare services in the emirate of Sharjah, the UAE, and the entire region. The hospital has most of the medical specialties such as the internal medicine, surgery, pediatrics, obstetrics and gynecology and other specialist departments such as natural therapy, therapeutic nutrition, and a neonatal intensive care unit equipped with latest technologies for recovery of premature infants, in addition to outpatient clinics, an emergency unit, and laboratory and radiology units, all managed by highly qualified medical and administrative staff.
The hospital accommodates 220 beds and has 6 operating rooms and a number of lecture halls. In April 2012 the UHS signed an agreement with Gustave-Roussy Institute of Oncology in France for the establishment of breast cancer diagnosis and treatment unit, the first of its kind in Sharjah and the Northern Emirates.